$MDAI News

MDAI: The Lull Between Approval and First Sale

Spectral AI, Inc. Q2 2026 Earnings Call Summary

Spectral AI, Inc. (MDAI) Q2 2026 Earnings Call Transcript

Spectral AI Q2 Earnings Call Highlights

Spectral AI Announces 2026 Second Quarter Financial Results

Spectral AI Q2 EPS $(0.13) Beats $(0.14) Estimate, Sales $3.524M Miss $4.145M Estimate

Spectral AI Affirms FY2026 Sales Guidance of $18.500M vs $18.538M Est

Spectral AI Schedules 2026 Second Quarter Financial Results and Conference Call

Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication

DeepView® System Highlighted at the 2026 British Burn Association Annual Conference

Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

Spectral AI to Participate in 2026 British Burn Association Annual Conference

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

MDAI: DeepView FDA Clearance Fires Up Our Valuation

BTIG Maintains Buy on Spectral AI, Raises Price Target to $4

BTIG Maintains Buy on Spectral AI, Raises Price Target to $4

Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication

Spectral AI Says FDA Grants De Novo Classification For Its DeepView System

MDAI: First Quarter 2026 Results

Spectral AI Inc (MDAI) Q1 2026 Earnings Call Highlights: Strategic Advances Amidst Financial ...